Copper Influences the Antibacterial Outcomes of a β-Lactamase-Activated Prochelator against Drug-Resistant Bacteria
- 20 March 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 4 (6), 1019-1029
- https://doi.org/10.1021/acsinfecdis.8b00037
Abstract
The unabated rise in bacterial resistance to conventional antibiotics, coupled with collateral damage to normal flora incurred by overuse of broad-spectrum antibiotics, necessitates the development of new antimicrobials targeted against pathogenic organisms. Here, we explore the antibacterial outcomes and mode of action of a prochelator that exploits the production of β-lactamase enzymes by drug-resistant bacteria to convert a non-toxic compound into a metal-binding antimicrobial agent directly within the microenvironment of pathogenic organisms. Compound PcephPT contains a cephalosporin core linked to 2-mercaptopyridine N-oxide (pyrithione) via one of its metal-chelating atoms, which minimizes its pre-activation interaction with metal ions and its cytotoxicity. Spectroscopic and chromatographic assays indicate that PcephPT releases pyrithione in the presence of β-lactamase-producing bacteria. The prochelator shows enhanced antibacterial activity against strains expressing β-lactamases, with bactericidal efficacy improved by the presence of low-micromolar copper in the growth medium. Metal analysis shows that cell-associated copper accumulation by the prochelator is significantly lower than that induced by pyrithione itself, suggesting that the location of pyrithione release influences biological outcomes. Low-micromolar (4–8 μg/mL) MIC values of PcephPT in ceftriaxone-resistant bacteria compared with LD50 values greater than 250 µM in mammalian cells suggests favorable selectivity. Further investigation into the mechanisms of prochelators will provide insight for the design of new antibacterial agents that manipulate cellular metallobiology as a strategy against infection.Keywords
Funding Information
- Division of Chemistry (CHE-1152054)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK110492)
- National Institute of Allergy and Infectious Diseases (AI121742)
- Division of Graduate Education (DGE 1644868)
- U.S. Department of Defense (W81XWH-13-0450)
- National Institute of General Medical Sciences (GM108494, GM084176)
This publication has 60 references indexed in Scilit:
- Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus BiofilmAntimicrobial Agents and Chemotherapy, 2015
- The Role of Copper and Zinc Toxicity in Innate Immune Defense against Bacterial PathogensJournal of Biological Chemistry, 2015
- Metal limitation and toxicity at the interface between host and pathogenFEMS Microbiology Reviews, 2014
- Enterobactin-Mediated Delivery of β-Lactam Antibiotics Enhances Antibacterial Activity against PathogenicEscherichia coliJournal of the American Chemical Society, 2014
- Metal-Induced Isomerization Yields an Intracellular Chelator that Disrupts Bacterial Iron HomeostasisCell Chemical Biology, 2014
- In vitro inhibition of bacterial growth by iron chelatorsFEMS Microbiology Letters, 2010
- Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium aviumMicrobes and Infection, 2010
- Effects of Chelators (Deferoxamine, Deferiprone and Deferasirox) on the Growth ofKlebsiella PneumoniaeandAeromonas HydrophilaIsolated from Transfusion-Dependent Thalassemia PatientsHemoglobin, 2009
- Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agentsBioMetals, 2009
- Iron Chelation Via Deferoxamine Exacerbates Experimental Salmonellosis Via Inhibition of the Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Dependent Respiratory BurstThe Journal of Immunology, 2002